Pharma Companies Face 'Tremendous' Uncertainty in China, Corporate Panelists Say

Pfizer's Gary Giampetruzzi and Daiichi Sankyo's Richard Konzelmann discussed China's recent anti-corruption crackdown at a panel in Washington, D.C.